VivoSeq
Other

In Vitro Fertilization

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

In Vitro Fertilization is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

81/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Merck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

27

clinical trials

Completed13 · 48%
Unknown status10 · 37%
Terminated2 · 7%
Withdrawn1 · 4%
Not yet recruiting1 · 4%

Clinical Trials

Trial Activity

27 trials

PREVenting-ENvIronment-Reprotoxic Exposures Before In Vitro Fertilization (PREVENIR-FIV)
Not yet recruiting·AAssistance Publique Hopitaux De Marseille·N/A·NCT06100523·4,224 enrolled
Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization
Completed·TThe First Affiliated Hospital of Zhengzhou University·N/A·NCT02496754·1,266 enrolled
Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment
Completed·FFaculdade de Medicina do ABC·N/A·NCT05225155·104 enrolled
Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment
Completed·MMeir Medical Center·N/A·NCT01145144
Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization
Completed·UUniversity of Turin, Italy·N/A·NCT02322398·848 enrolled
A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)
Completed·Merck & Co. logoMerck & Co.·Phase 3·NCT01081756·218 enrolled
Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization
Completed·NNew Hope Fertility Center·N/A·NCT02865681·4 enrolled
Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles
Completed·SShangHai Ji Ai Genetics & IVF Institute·Phase 4·NCT02866253·78 enrolled
Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.
Completed·IInstituto de Investigacion Sanitaria La Fe·Phase 3·NCT02118051·234 enrolled
Relationship Between Some Vitamins and Antioxidants With in Vitro Fertilization Outcomes
Completed·—·N/A·NCT05393011·60 enrolled
Basal Androgens and LH Needing for Ovarian Stimulation for in Vitro Fertilization
Completed·IInstituto Valenciano de Infertilidad, IVI VALENCIA·Phase 3·NCT01563809·400 enrolled
Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs
Completed·FFertility Centers of Illinois·Phase 4·NCT01465373·10 enrolled
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
Completed·DDuramed Research·Phase 3·NCT00615251·1,297 enrolled
Androgens for Poor Responders in In Vitro Fertilization
Completed·HHospital Clinic of Barcelona·Phase 3·NCT00693108
The Luveris In Vitro Fertilization Trial
Terminated·UUniversity Reproductive Associates·Phase 4·NCT00889512·14 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)